HomeEXECUTIVES
EXECUTIVES
The medical device news magazine is the latest source for industry scoop. In this article, we take a look at which executives are on the move.
As the medical device industry rapidly expands, so does the need for executive leadership. Recently, several top executives have made moves within the industry. Some have taken new positions at other companies, while others have started their own businesses. Here’s a look at who’s been making headlines lately.
Dr Efthymios Deliargyris Appointed New CMO of Cytosorbents
Dr Efthymios Deliargyris brings over 19 years of experience in both academic medicine and industry to the position of Chief Medical Officer.
John Murphy PhD Appointed GTX Medical BV Chief Technology Officer
John Murphy PhD joins the company with over twenty years of experience in Class I, II, and III medical devices and implantables and has been instrumental in bringing numerous new devices to commercialization.
Dan Myers Appointed CEO of Leo Lens Pharma
Prior to joining Leo Lens Pharma, Dan Myers was the co-founder and Chief Executive Officer of Alimera Sciences, where he continues to serve as chairman of the Board of Directors.
CHPA Welcomes Procter & Gamble’s Paul Gama as Board Chair
Gama is President of Personal Health Care (PHC) for The Procter & Gamble Company (P&G), leading their global healthcare portfolio of OTC medicines, dietary supplements, and consumer medical devices.
Nathan Diers Promoted Vice President of EyeKor Product Development
Yijun Huang, CEO of EyeKor, is thrilled with this new promotion. Huang said, "Nathan Diers has been an integral part of EyeKor's growth.
Charlie Alvarez Appointed Alliance Family of Companies CEO
Charlie Alvarez brings more than 30 years of healthcare leadership experience and most recently served as CEO of DCI Health Technologies, Inc.
David Long Named CFO of Cynosure
David Long will help accelerate the company's business transformation and growth plans under the new leadership of Chief Executive Officer and former Hershey and Unilever executive, Todd Tillemans.
Jay M Moyes Appointed New CFO of Sera Prognostics
Jay M Moyes joins Sera Prognostics as it transitions from rigorous scientific and groundbreaking clinical stage company into a rapidly growing commercial organization.
Roy Tanaka Joins S4 Medical’s Board of Directors
Roy Tanaka brings years of experience to S4. Tanaka joined Biosense Webster, a Johnson & Johnson company, in 1997 as U.S. president, and became its worldwide president in 2004 until his retirement in 2008.
